清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Nonpharmacologic and Pharmacologic Treatments of Adults in the Acute Phase of Major Depressive Disorder: A Living Clinical Guideline From the American College of Physicians

医学 重性抑郁障碍 指南 认知行为疗法 精神科 人口 重症监护医学 物理疗法 认知 环境卫生 病理
作者
Amir Qaseem,Douglas K Owens,Itziar Etxeandia‐Ikobaltzeta,Janice Tufte,J. Thomas Cross,Timothy J Wilt
出处
期刊:Annals of Internal Medicine [American College of Physicians]
卷期号:176 (2): 239-252 被引量:113
标识
DOI:10.7326/m22-2056
摘要

Description: The purpose of this guideline from the American College of Physicians (ACP) is to present updated clinical recommendations on nonpharmacologic and pharmacologic interventions as initial and second-line treatments during the acute phase of a major depressive disorder (MDD) episode, based on the best available evidence on the comparative benefits and harms, consideration of patient values and preferences, and cost. Methods: The ACP Clinical Guidelines Committee based these recommendations on an updated systematic review of the evidence. Audience and Patient Population: The audience for this guideline includes clinicians caring for adult patients in the acute phase of MDD in ambulatory care. The patient population includes adults in the acute phase of MDD. Recommendation 1a: ACP recommends monotherapy with either cognitive behavioral therapy or a second-generation antidepressant as initial treatment in patients in the acute phase of moderate to severe major depressive disorder (strong recommendation; moderate-certainty evidence). Recommendation 1b: ACP suggests combination therapy with cognitive behavioral therapy and a second-generation antidepressant as initial treatment in patients in the acute phase of moderate to severe major depressive disorder (conditional recommendation; low-certainty evidence). The informed decision on the options of monotherapy with cognitive behavioral therapy versus second-generation antidepressants or combination therapy should be personalized and based on discussion of potential treatment benefits, harms, adverse effect profiles, cost, feasibility, patients' specific symptoms (such as insomnia, hypersomnia, or fluctuation in appetite), comorbidities, concomitant medication use, and patient preferences. Recommendation 2: ACP suggests monotherapy with cognitive behavioral therapy as initial treatment in patients in the acute phase of mild major depressive disorder (conditional recommendation; low-certainty evidence). Recommendation 3: ACP suggests one of the following options for patients in the acute phase of moderate to severe major depressive disorder who did not respond to initial treatment with an adequate dose of a second-generation antidepressant: • Switching to or augmenting with cognitive behavioral therapy (conditional recommendation; low-certainty evidence) • Switching to a different second-generation antidepressant or augmenting with a second pharmacologic treatment (see Clinical Considerations) (conditional recommendation; low-certainty evidence) The informed decision on the options should be personalized and based on discussion of potential treatment benefits, harms, adverse effect profiles, cost, feasibility, patients' specific symptoms (such as insomnia, hypersomnia, or fluctuation in appetite), comorbidities, concomitant medication use, and patient preferences.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
5秒前
ZDU完成签到 ,获得积分10
13秒前
深情安青的应助被东风采纳,获得10
15秒前
完美世界的应助被东风采纳,获得10
16秒前
FashionBoy的应助被东风采纳,获得10
16秒前
科研通AI65的应助被东风采纳,获得10
16秒前
SciGPT的应助被东风采纳,获得10
16秒前
小蘑菇的应助被东风采纳,获得10
16秒前
Maestro_S的应助被东风采纳,获得50
16秒前
余香的应助被东风采纳,获得10
16秒前
打打的应助被东风采纳,获得10
16秒前
Maestro_S的应助被东风采纳,获得10
16秒前
wary发布了新的文献求助10
18秒前
高大的凡阳完成签到 ,获得积分10
31秒前
33秒前
qianci2009完成签到,获得积分0
36秒前
可爱的函函的应助被东风采纳,获得10
36秒前
彭于晏的应助被东风采纳,获得10
36秒前
科研通AI6.2的应助被东风采纳,获得10
36秒前
科研通AI6.4的应助被东风采纳,获得10
37秒前
JamesPei的应助被东风采纳,获得10
37秒前
科研通AI6.4的应助被东风采纳,获得10
37秒前
完美世界的应助被东风采纳,获得10
37秒前
科研通AI65的应助被东风采纳,获得10
37秒前
科研通AI6.3的应助被东风采纳,获得10
37秒前
余香的应助被东风采纳,获得10
37秒前
清爽水之完成签到,获得积分10
39秒前
nanjing01完成签到 ,获得积分10
45秒前
余香的应助被东风采纳,获得10
55秒前
共享精神的应助被东风采纳,获得10
55秒前
Maestro_S的应助被东风采纳,获得50
55秒前
英姑的应助被东风采纳,获得10
55秒前
华仔的应助被东风采纳,获得10
55秒前
科研通AI6.3的应助被东风采纳,获得10
56秒前
科研通AI6.2的应助被东风采纳,获得10
56秒前
CodeCraft的应助被东风采纳,获得10
56秒前
余香的应助被东风采纳,获得10
56秒前
科研通AI6.3的应助被东风采纳,获得30
56秒前
自然的雨琴完成签到,获得积分10
1分钟前
yanglinhai完成签到 ,获得积分10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190280
求助须知:如何正确求助?哪些是违规求助? 9577382
关于积分的说明 21852440
捐赠科研通 7788866
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560109
邀请新用户注册赠送积分活动 2482945